Skip to main content

Advertisement

Log in

Functional Characterization of Interferon Regulation Element of Hepatitis B virus Genome In Vivo

  • Original Article
  • Published:
Indian Journal of Virology Aims and scope Submit manuscript

Abstract

The roles of interferon regulatory element (IRE) in Hepatitis B virus (HBV) genome on inhibitory effect of interferon against HBV are controversial in vitro. This study aimed to determine the functional characterization of HBV-IRE sequence in vivo. Wild-type or IRE-mutant HBV replication-competent mice were firstly established, and mice were subquently treated with polyinosinic-polytidylin acid (polyI.C) or phosphate-buffered saline via intraperitoneal. Results showed that PolyI.C inhibited viral replication, and increased the level of 2′,5′-oligoadenylate synthase mRNA transcripts, a marker of INF-α/β induction. Between wild-type and IRE-mutant HBV replication-competent mice, the levels of HBV-RNA and HBV-DNA replication intermediates were similar. After PolyI.C treatment, the decreasing of HBV-RNA was similar between two groups, but HBV-DNA replication intermediates decreased significantly less in IRE-mutant than wild-type HBV replication-competent mice. These findings suggested that IRE mutant reduced the inhibitory effect of interferon on HBV replication, which played a role in antiviral effect of interferon against HBV.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Alcantara FF, Tang H, McLachlan A. Functional characterization of the interferon regulatory element in the enhancer 1 region of the hepatitis B virus genome. Nucleic Acids Res. 2002;30:2068–75.

    Article  PubMed  CAS  Google Scholar 

  2. Barry G, Breakwell L, Fragkoudis R, Attarzadeh-Yazdi G, Rodriguez-Andres J, Kohl A, Fazakerley JK. PKR acts early in infection to suppress Semliki Forest virus production and strongly enhances the type I interferon response. J Gen Virol. 2009;90:1382–91.

    Article  PubMed  CAS  Google Scholar 

  3. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet. 1981;2:1129–33.

    Article  PubMed  CAS  Google Scholar 

  4. Bonjardim CA, Ferreira PC, Kroon EG. Interferons: signaling, antiviral and viral evasion. Immunol Lett. 2009;122:1–11.

    Article  PubMed  CAS  Google Scholar 

  5. Chen DS, Hepatitis B. Vaccination: the key towards elimination and eradication of hepatitis B. J Hepatol. 2009;50:805–16.

    Article  PubMed  Google Scholar 

  6. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264:1415–21.

    Article  PubMed  CAS  Google Scholar 

  7. Der SD, Zhou A, Williams BR, Silverman RH. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci USA. 1998;95:15623–8.

    Article  PubMed  CAS  Google Scholar 

  8. Di Marco V, Craxi A. Chronic hepatitis B: who to treat and which choice of treatment? Expert Rev Anti Infect Ther. 2009;7:281–91.

    Article  PubMed  Google Scholar 

  9. Fujiyama A, Miyanohara A, Nozaki C, Yoneyama T, Ohtomo N, Matsubara K. Cloning and structural analyses of hepatitis B virus DNAs, subtype adr. Nucleic Acids Res. 1983;11:4601–10.

    Article  PubMed  CAS  Google Scholar 

  10. Guidotti LG, Eggers CM, Raney AK, Chi SY, Peters JM, Gonzalez FJ, McLachlan A. In vivo regulation of hepatitis B virus replication by peroxisome proliferators. J Virol. 1999;73:10377–86.

    PubMed  CAS  Google Scholar 

  11. Haller O, Kochs G, Weber F. Interferon, Mx, and viral countermeasures. Cytokine Growth Factor Rev. 2007;18:425–33.

    Article  PubMed  CAS  Google Scholar 

  12. Hovanessian AG. On the discovery of interferon-inducible, double-stranded RNA activated enzymes: the 2′-5′oligoadenylate synthetases and the protein kinase PKR. Cytokine Growth Factor Rev. 2007;18:351–61.

    Article  PubMed  CAS  Google Scholar 

  13. Jafri SM, Lok AS. Antiviral therapy for chronic hepatitis B. Clin Liver Dis. 2010;14:425–38.

    Article  PubMed  Google Scholar 

  14. Ju Y, Hou N, Zhang XN, Zhao D, Liu Y, Wang JJ, Luan F, Shi W, Zhu FL, Sun WS, Zhang LN, Gao CJ, Gao LF, Liang XH, Ma CH. Blockade of Tim-3 pathway ameliorates interferon-gamma production from hepatic CD8+ T cells in a mouse model of hepatitis B virus infection. Cell Mol Immunol. 2009;6:35–43.

    Article  PubMed  CAS  Google Scholar 

  15. Kalvakolanu DV, Borden EC. An overview of the interferon system: signal transduction and mechanisms of action. Cancer Invest. 1996;14:25–53.

    Article  PubMed  CAS  Google Scholar 

  16. Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, Tobias H. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association. 2008;6:1315–41. quiz 286.

    CAS  Google Scholar 

  17. Kim SR, Kudo M, Hino O, Han KH, Chung YH, Lee HS. Epidemiology of hepatocellular carcinoma in Japan and Korea. A review. Oncology. 2008;75(Suppl 1):13–6.

    Article  PubMed  Google Scholar 

  18. Kimura T, Kadokawa Y, Harada H, Matsumoto M, Sato M, Kashiwazaki Y, Tarutani M, Tan RS, Takasugi T, Matsuyama T, Mak TW, Noguchi S, Taniguchi T. Essential and non-redundant roles of p48 (ISGF3 gamma) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies. Genes Cells. 1996;1:115–24.

    Article  PubMed  CAS  Google Scholar 

  19. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol. 2005;34(Suppl 1):S1–3.

    Article  PubMed  Google Scholar 

  20. Liu F, Song Y, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 1999;6:1258–66.

    Article  PubMed  CAS  Google Scholar 

  21. Liu FJ, Liu L, He F, Wang S, Zhou TY, Liu C, Deng LY, Tang H. Establishment and primary application of a mouse model with hepatitis B virus replication. World J Gastroenterol. 2007;13:5324–30.

    PubMed  CAS  Google Scholar 

  22. Luo Y, Lo CM, Cheung CK, Lau GK, Wong J. Hepatitis B virus-specific CD4 T cell immunity after liver transplantation for chronic hepatitis B. Liver Transpl. 2009;15:292–9.

    Article  PubMed  Google Scholar 

  23. Mucha R, Bhide MR, Chakurkar EB, Novak M, Mikula I Sr. Toll-like receptors TLR1, TLR2 and TLR4 gene mutations and natural resistance to Mycobacterium avium subsp. paratuberculosis infection in cattle. Vet Immunol Immunopathol. 2009;128:381–8.

    Article  PubMed  CAS  Google Scholar 

  24. Nakao K, Nakata K, Yamashita M, Tamada Y, Hamasaki K, Ishikawa H, Kato Y, Eguchi K, Ishii N. p48 (ISGF-3gamma) is involved in interferon-alpha-induced suppression of hepatitis B virus enhancer-1 activity. J Biol Chem. 1999;274:28075–8.

    Article  PubMed  CAS  Google Scholar 

  25. Okamoto H, Imai M, Shimozaki M, Hoshi Y, Iizuka H, Gotanda T, Tsuda F, Miyakawa Y, Mayumi M. Nucleotide sequence of a cloned hepatitis B virus genome, subtype ayr: comparison with genomes of the other three subtypes. J Gen Virol. 1986;67(Pt 11):2305–14.

    Article  PubMed  CAS  Google Scholar 

  26. Rang A, Heise T, Will H. Lack of a role of the interferon-stimulated response element-like region in interferon alpha -induced suppression of Hepatitis B virus in vitro. J Biol Chem. 2001;276:3531–5.

    Article  PubMed  CAS  Google Scholar 

  27. Reich N, Evans B, Levy D, Fahey D, Knight E Jr, Darnell JE Jr. Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element. Proc Natl Acad Sci USA. 1987;84:6394–8.

    Article  PubMed  CAS  Google Scholar 

  28. Robek MD, Boyd BS, Wieland SF, Chisari FV. Signal transduction pathways that inhibit hepatitis B virus replication. Proc Natl Acad Sci USA. 2004;101:1743–7.

    Article  PubMed  CAS  Google Scholar 

  29. Suzuki T, Takehara T, Ohkawa K, Ishida H, Jinushi M, Miyagi T, Sasaki Y, Hayashi N. Intravenous injection of naked plasmid DNA encoding hepatitis B virus (HBV) produces HBV and induces humoral immune response in mice. Biochem Biophys Res Commun. 2003;300:784–8.

    Article  PubMed  CAS  Google Scholar 

  30. Tang H, McLachlan A. Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism. Proc Natl Acad Sci USA. 2001;98:1841–6.

    Article  PubMed  CAS  Google Scholar 

  31. Tang H, Delgermaa L, Huang F, Oishi N, Liu L, He F, Zhao L, Murakami S. The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. J Virol. 2005;79:5548–56.

    Article  PubMed  CAS  Google Scholar 

  32. Wang J, Jiang D, Zhang H, Lv S, Rao H, Fei R, Wei L. Proteome responses to stable hepatitis B virus transfection and following interferon alpha treatment in human liver cell line HepG2. Proteomics. 2009;9:1672–82.

    Article  PubMed  CAS  Google Scholar 

  33. Wiegand J, Hasenclever D, Tillmann HL. Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence. Antivir Ther. 2008;13:211–20.

    PubMed  CAS  Google Scholar 

  34. Yang PL, Althage A, Chung J, Chisari FV. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc Natl Acad Sci USA. 2002;99:13825–30.

    Article  PubMed  CAS  Google Scholar 

  35. Zhang Q, Wei L, Wang Y. ISGF3, a critical factor of the IFN-alpha pathway in the antiviral action of HBV. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2005;19:110–3.

    PubMed  CAS  Google Scholar 

  36. Zhang Q, Wang Y, Wei L, Jiang D, Wang JH, Rao HY, Zhu L, Chen H, Fei R, Cong X. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro. J Gastroenterol Hepatol. 2008;23:1747–61.

    Article  PubMed  CAS  Google Scholar 

  37. Zhou A, Hassel BA, Silverman RH. Expression cloning of 2–5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell. 1993;72:753–65.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by National Key Technologies Research and Development Program of China (2012ZX10002007 and 2008ZX10002-006), National Natural Science Foundation of China (No. 30972622), and National Basic Research Program of China (No.2007CB512902).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hong Tang.

Additional information

Feng-Jun Liu, En-Qiang Chen contributed equally to this paper.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, FJ., Chen, EQ., Zhou, QL. et al. Functional Characterization of Interferon Regulation Element of Hepatitis B virus Genome In Vivo. Indian J. Virol. 23, 278–285 (2012). https://doi.org/10.1007/s13337-012-0091-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13337-012-0091-2

Keywords

Navigation